Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics Symposium Series

Volumn 2, Issue 1, 2006, Pages 58-64

  Ando, T ^a   Minami, M ^a   Ishiguro, K ^a   Maeda, O ^a   Watanabe, O ^a   Mizuno, T ^a   Fujita, T ^a   Takahashi, H ^a   Noshiro, M ^a   Goto, H ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ATHEROSCLEROSIS; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 34247842855     PISSN: 17466334     EISSN: 17466342     Source Type: Journal    
DOI: 10.1111/j.1746-6342.2006.00026.x     Document Type: Conference Paper

References (50)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link Lancet 1997 350:430 6.
2. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 2000 20:1057 60.
3. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997 17:1121 7.
4. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998 98:731 3.
5. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J 2000 321:199 204.
6. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998 279:1477 82.
7. Markowe HL, Marmot MG, Shipley MJ, et al. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) 1985 291:1312 4.
8. Meade TW, Ruddock V, Stirling Y, et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993 342:1076 9.
9. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984 1:1311 5.
10. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995 55:2111 5.
11. Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999 179:1523 30.
12. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992 102:720 7.
13. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001 15:1271 90.
14. Craig PM, Territo MC, Karnes WE, et al. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 1992 33:1020 3.
15. Mai UE, Perez-Perez GI, Allen JB, et al. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992 175:517 25.
16. Nielsen H, Andersen LP. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut 1992 33:738 42.
17. Ando T, Kusugami K, Ohsuga M, et al. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol 1996 91:1150 6.
18. Ando T, Kusugami K, Ohsuga M, et al. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infect Immun 1998 66:4742 7.
19. Crabtree JE, Farmery SM, Lindley IJ, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994 47:945 50.
20. Crowe SE, Alvarez L, Dytoc M, et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995 108:65 74.
21. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol 1994 1:229 46.
22. Kishimoto T. The biology of interleukin-6. Blood 1989 74:1 10.
23. Capurso G, Lahner E, Marcheggiano A, et al. Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther 2001 15:1753 61.
24. Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998 352:878.
25. Grimaz S, Damiani D, Brosolo P, et al. Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica 1999 84:283 4.
26. Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001 97:812 4.
27. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002 118:584 8.
28. Ando T, Tsuzuki T, Mizuno T, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004 9:443 52.
29. Zentilin P, Seriolo B, Dulbecco P, et al. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 2002 16:1291 9.
30. de Luis DA, Varela C, de La Calle H, et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998 26:259 63.
31. Ridker PM, Danesh J, Youngman L, et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med 2001 135:184 8.
32. Majka J, Rog T, Konturek PC, et al. Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors. Med Sci Monit 2002 8:CR675 84.
33. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000 293:31 52.
34. Niemela S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations Heart 1996 75:573 5.
35. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. Circulation 1998 98:1286 90.
36. Azuma T, Suto H, Ito Y, et al. Gastric leptin and Helicobacter pylori infection. Gut 2001 49:324 9.
37. Nwokolo CU, Freshwater DA, O'Hare P, et al. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003 52:637 40.
38. Breidert M, Miehlke S, Glasow A, et al. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1999 34:954 61.
39. Goiot H, Attoub S, Kermorgant S, et al. Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology 2001 121:1417 27.
40. Konturek JW, Konturek SJ, Kwiecien N, et al. Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori. Scand J Gastroenterol 2001 36:1148 54.
41. Schneider R, Bornstein SR, Chrousos GP, et al. Leptin mediates a proliferative response in human gastric mucosa cells with functional receptor. Horm Metab Res 2001 33:1 6.
42. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001 120:337 45.
43. Lee HM, Wang G, Englander EW, et al. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002 143:185 90.
44. Wang G, Lee HM, Englander E, et al. Ghrelin - not just another stomach hormone. Regul Pept 2002 105:75 81.
45. Gokcel A, Gumurdulu Y, Kayaselcuk F, et al. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 2003 148:423 6.
46. Isomoto H, Nakazato M, Ueno H, et al. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med 2004 117:429 32.
47. Chimienti G, Russo F, Lamanuzzi BL, et al. Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a). Clin Biochem 2003 36:359 65.
48. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995 311:7114.
49. Nakao M, Malfertheiner P. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter 1998 3:21 7.
50. Dattilo M, Figura N. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. J Clin Gastroenterol 1998 27 (Suppl 1 S163 9.